$660 Million is the total value of Adventist Health System/ West's 6 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 20.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VTI | Sell | VANGUARD INDEX FDStotal stk mkt | $438,649,000 | -16.5% | 1,975,364 | -16.2% | 66.47% | -13.6% |
IEFA | Buy | ISHARES TRcore msci eafe | $81,298,000 | +78.6% | 1,094,924 | +80.1% | 12.32% | +84.9% |
IEMG | Buy | ISHARES INCcore msci emkt | $66,668,000 | +141.9% | 1,079,476 | +162.4% | 10.10% | +150.4% |
VTIP | Buy | VANGUARD MALVERN FDSstrm infproidx | $51,326,000 | +20.4% | 976,150 | +20.0% | 7.78% | +24.6% |
VTV | Sell | VANGUARD INDEX FDSvalue etf | $21,685,000 | -48.4% | 160,187 | -47.6% | 3.29% | -46.6% |
VCSH | New | VANGUARD SCOTTSDALE FDSshrt trm corp bd | $338,000 | – | 4,098 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 20 | Q3 2023 | 20.4% |
ISHARES INC | 19 | Q3 2023 | 17.2% |
VANGUARD MALVERN FDS | 17 | Q3 2023 | 10.9% |
VANGUARD INDEX FDS | 13 | Q4 2021 | 95.4% |
ISHARES TR | 7 | Q3 2023 | 60.4% |
VANGUARD SCOTTSDALE FDS | 7 | Q3 2023 | 10.1% |
VANGUARD INDEX FDS | 4 | Q4 2021 | 6.2% |
PREMIER INC | 1 | Q3 2020 | 14.9% |
VANGUARD BD INDEX FD INC | 1 | Q4 2018 | 1.2% |
VANGUARD SCOTTSDALE FDS | 1 | Q3 2021 | 0.1% |
View Adventist Health System/ West's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Adventist Health System/ West's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.